Shiho Kawagoe
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Differences in Itch Quality Between Interleukin-31 and Thymus and Activation-Regulated Chemokine of Japanese Atopic Dermatitis.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: September 17, 2025
Generation of human-pig chimeric renal organoids using iPSC technology.
Journal: Communications biology
Published: April 22, 2024
Caspase 9-induced apoptosis enables efficient fetal cell ablation and disease modeling.
Journal: Nature communications
Published: April 09, 2024
Generation of induced pluripotent stem cell (iPSC) from NY-ESO-I-specific cytotoxic T cells isolated from the melanoma patient with minor HLAs: The practical pilot study for the adoptive immunotherapy for melanoma using iPSC technology.
Journal: Experimental dermatology
Published: August 05, 2022
Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.
Journal: Journal of dermatological science
Published: February 13, 2020
Analysis of Response Evaluation Criteria in Solid Tumors reduction ratio of primary chemotherapy in unresectable advanced or recurrent colorectal cancer.
Journal: Molecular and clinical oncology
Published: September 13, 2018
Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion-deletion complex mutation in the FOXC2 gene.
Journal: Stem cell research
Published: March 11, 2016
The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCs.
Journal: Molecular genetics and metabolism
Published: January 24, 2014
Last Updated: 09/26/2026